ATE304593T1 - Menschliches gen und protein eines magenkrebs- antigens - Google Patents

Menschliches gen und protein eines magenkrebs- antigens

Info

Publication number
ATE304593T1
ATE304593T1 AT99305469T AT99305469T ATE304593T1 AT E304593 T1 ATE304593 T1 AT E304593T1 AT 99305469 T AT99305469 T AT 99305469T AT 99305469 T AT99305469 T AT 99305469T AT E304593 T1 ATE304593 T1 AT E304593T1
Authority
AT
Austria
Prior art keywords
gastric cancer
protein
cell
cancer antigen
induce
Prior art date
Application number
AT99305469T
Other languages
English (en)
Inventor
Kokichi Kikuchi
Noriyuki Sato
Toshihiko Torigoe
Hiroeki Sahara
Manabu Suzuki
Junji Hamuro
Original Assignee
Ajinomoto Kk
Kokichi Kikuchi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk, Kokichi Kikuchi filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of ATE304593T1 publication Critical patent/ATE304593T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99305469T 1998-07-13 1999-07-09 Menschliches gen und protein eines magenkrebs- antigens ATE304593T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10197852A JP2000023673A (ja) 1998-07-13 1998-07-13 ヒト胃癌抗原遺伝子および胃癌抗原蛋白質

Publications (1)

Publication Number Publication Date
ATE304593T1 true ATE304593T1 (de) 2005-09-15

Family

ID=16381418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99305469T ATE304593T1 (de) 1998-07-13 1999-07-09 Menschliches gen und protein eines magenkrebs- antigens

Country Status (5)

Country Link
US (2) US6444800B1 (de)
EP (1) EP0974653B1 (de)
JP (1) JP2000023673A (de)
AT (1) ATE304593T1 (de)
DE (1) DE69927214T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09151200A (ja) * 1995-09-29 1997-06-10 Ajinomoto Co Inc ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤
US7226548B2 (en) * 2002-11-11 2007-06-05 Conocophillips Company Syngas catalysts and their method of use
CN101472943B (zh) * 2006-06-16 2013-07-17 肿瘤疗法·科学股份有限公司 来自sparc的癌排斥抗原肽以及含有该肽的药物
DE102023001827A1 (de) 2023-04-19 2024-10-24 Horst Wochnowski Verfahren und dazugehörige Vorrichtung zum Züchten von in Gewässern Mikroplastik zersetzenden und abbauenden Mikroorganismenstämme durch einen künstlich herbeigeführten und beschleunigten Evolutions- und Selektionsprozess

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09151200A (ja) 1995-09-29 1997-06-10 Ajinomoto Co Inc ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤
US5932442A (en) * 1997-09-23 1999-08-03 Incyte Pharmaceuticals, Inc. Human regulatory molecules
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides

Also Published As

Publication number Publication date
EP0974653B1 (de) 2005-09-14
US20020173642A1 (en) 2002-11-21
DE69927214D1 (de) 2005-10-20
US7030222B2 (en) 2006-04-18
EP0974653A2 (de) 2000-01-26
DE69927214T2 (de) 2006-07-06
JP2000023673A (ja) 2000-01-25
US6444800B1 (en) 2002-09-03
EP0974653A3 (de) 2001-09-19

Similar Documents

Publication Publication Date Title
CY1119285T1 (el) Φορεις εμβολιου αδενοϊου χιμπατζη
AU2003242305A8 (en) Hla-a24-restricted cancer antigen peptide
CY1113379T1 (el) Πεπτιδια κdr και εμβολια που τα περιλαμβανουν
ES2373055T3 (es) Péptido antígeno de rechazo de cáncer derivado de glipican-3 (gpc3) para uso en pacientes positivos a la hla-a2 y producto farmacéutico que comprende el antígeno.
ES2365077T3 (es) Péptido antígeno anticáncer derivado de sparc y composición farmacéutica que comprende el mismo.
DE69924826T8 (de) Verwendung vom krebs-assoziierten antigen 5t4 zur immuntherapie
DK1536006T3 (da) Cancerantigener og anvendelse deraf
JP2018506287A5 (de)
HUP0100267A2 (hu) Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények
GB0031430D0 (en) Polypeptides
DE69927214D1 (de) Menschliches Gen und Protein eines Magenkrebs-Antigens
ATE369895T1 (de) Modifizierte cea nucleinsäure und expressionsvektoren
WO2002094859A3 (en) Mage-a1 peptides for treating or preventing cancer
ATE95065T1 (de) Methode und mittel zur vorbeugenden behandlung von autoimmunkrankheiten.
ATE207536T1 (de) Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6
JP2006096663A (ja) 癌遺伝子ワクチン
WO2005058944A3 (en) Immunogenic peptides fragments of xage-1
ZA200703875B (en) Plasmids coding for P185NEU protein sequence variants and therapeutic uses thereof
DE502006004924D1 (de) Therapeutsche zusammensetzung zur vorbeugung und bekämpfung von knochenmetastasen
JP2003277288A5 (de)
JP2003277289A5 (de)
JP2006129832A (ja) ＣａｔｈｅｐｓｉｎＨタンパク質由来のＣＤ８＋細胞傷害性Ｔリンパ球ｍＨＡエピトープペプチド及びその用途
WO2002064628A3 (en) Isolated human transporter proteins nucleic acids and use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties